chronic kidney disease, diagnosis, management, prognosis, complications, renal replacement therapy, when to initiate hemodialysis, complication of hemodialysis, mortality and morbility.
Brief explanation of each *refer harrison textbook for details causes of TIN
Acute interstitial nephritis
Chronic interstitial nephritis
Reflux nephropathy
Papillary necrosis
Sickle-cell nephropathy
chronic kidney disease, diagnosis, management, prognosis, complications, renal replacement therapy, when to initiate hemodialysis, complication of hemodialysis, mortality and morbility.
Brief explanation of each *refer harrison textbook for details causes of TIN
Acute interstitial nephritis
Chronic interstitial nephritis
Reflux nephropathy
Papillary necrosis
Sickle-cell nephropathy
Acute renal failure or acute kidney injury is characterized by determination of renal functions over a period of hours to few days, resulting in failure of the kidney to excrete nitrogenous waste product and to maintain fluid, electrolytes and acid-base homeostasis.
A presentation on the pathology and current management (with Especial emphasis on surgical management) of Portal Hypertension; a common complication of liver cirrhosis among other liver diseases. Being a copy of seminar presentation I for the HepatoPancreaticoBiliary Unit of the Division of General Surgery, Ahmadu Belllo University Teaching Hospital, Zaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
2. Must know Must do
• Must know
• Causes, types and management of ARF
• List of commonly used drugs, including
antibiotics and analgesics, known to cause
renal damage
• Principles of renal replacement therapy
3. Must do
• Clerk patients with chronic renal
disease/failure
• Follow patients being treated for ARF
• Become familiar with the biochemistry of
renal failure
4. Must do
• Become proficient in catheterizing male and
female patients
• Observe patients undergoing haemodialysis
and haemofiltration
• Observe cadaveric-donor and living-donor-
related renal transplantation
6. • Acute renal failure (ARF) is defined as the
rapid onset of renal impairment resulting in
the accumulation of nitrogenous waste
products, i.e. urea and creatinine, within the
body.
7. Causes of irreversibility
• 1-Pre-existing renal damage (acute-on-chronic
renal failure)
• 2-Irreversible damage
• 3-Delays in treatment
8. ATN/ ARF
• Acute tubular necrosis (ATN) is used to denote
ARF where there is intrinsic but reversible
damage to the kidney.
9. Sudden anuria or oliguria
• ARF commonly presents with sudden anuria
(no urine) or oliguria (< 400 mL/day).
10. Non-oliguric renal failure
• Non-oliguric renal failure may also occur and
is recognized by a persistently rising serum
creatinine level in the presence of normal
output of urine.
16. The causes of prerenal ARF
• Reduced cardiac output
• Acute myocardial infarction
• Cardiac arrest
• Cardiac failure
• Significant valvular disease
• Cardiac tamponade
• Depleted circulating volume
• Sepsis
• Haemorrhage
• Hypoalbuminaemia
• Depleted extracellular fluid volume
• Loss from gastrointestinal tract with diarrhoea, vomiting
• Loss from urinary tract due to excessive diuresis
• Loss from skin/body surface associated with sweating and
• Burns
• Vascular disease
• Renal artery thrombosis/embolism
17. Prerenal ARF
• Prerenal ARF can progress to ATN (intrinsic
ARF) if the underlying cause is not reversed
promptly, although instrinsic ARF may arise
directly from other causes
18. Postrenal failure
• Postrenal failure, which results from
obstruction to urinary flow, is categorized as
obstructive uropathy
• When the kidney is obstructed, glomerular
function does not cease completely because
the filtrate is reabsorbed by the renal
lymphatics and veins.
19. Postrenal failure
• Unrelieved, obstruction leads to ischaemic
renal damage mediated by vasoactive
hormones including renin, angiotensin,
endothelin, etc.
20. Postrenal failure
• Return to useful function depends on
duration/degree of obstruction and the
presence/absence of infection above the
obstruction.
21. Postrenal failure
• Following relief of obstruction, recovery of
tubular function lags behind restoration of
glomerular filtration rate (GFR), resulting in a
diuresis.
23. Inadequate/delayed treatment of
prerenal acute renal failure
• Most common cause in surgical practice:-
• 1-Ischaemia and toxin
• 2-Hypercalcaemia
• 3-Hepatorenal syndrome
31. ARF/ Shock/↓RBF
• ARF may occur as a consequence of shock.
• The reduction in circulating blood volume
produces a significant decrease in renal blood
flow, which may fall to one-third of its normal
level
32. ↓GFR
• The GFR is correspondingly reduced and the
patient becomes oliguric, producing only 400-
700 ml of urine per 24 h, or less than 20 mL/h.
• When oligaemic states cause a reduction in
renal blood flow, additional changes take
place.
33. ↓↓↓GFR
• There is a diversion of blood from the renal
cortex and this exacerbates the situation by
causing a further reduction in GFR
34. ↓RBF of Brief Duration
• If the impairment in renal blood flow is of
brief duration and blood volume is restored
rapidly, the condition can be reversed and
normal urine output resumed, although
sometimes there is a lapse of some hours
before this takes place
35. Prolonged ischaemic insult
• A more prolonged ischaemic insult causes
ATN, with oliguria persisting for 1 to 3 or 4
weeks, followed by a period of diuresis when
large volumes of dilute urine are passed each
day.
36. Profound Ischaemia
• More profound ischaemia gives rise to cortical
necrosis, an irreversible condition requiring
renal dialysis and eventually renal transplant
37. • Once ARF becomes established, serious water
and electrolyte disturbances occur
38. Oliguric Phase
• During the oliguric phase, water retention
with a relatively low Na+ may precipitate
cardiac failure, accompanied by pulmonary
and systemic oedema.
• The degree of dyspnoea may be sufficiently
severe to warrant ventilatory support.
39. Arrhythmias→ Cardiac arrest
• Inability to excrete K+ leads to dangerously
high plasma levels, which may give rise to
arrhythmias and, if uncontrolled, to cardiac
arrest.
40. Retention of H+ ions
• Retention of H+ ions precipitates metabolic
acidosis.
• At first, hyperventilation and respiratory
alkalosis compensate for this but these
mechanisms eventually fail and the pH of the
blood falls rapidly.
• This phase may be exacerbated by respiratory
failure and a developing lactic acidosis.
41. Retention of H+ ions
• Both the blood urea and serum creatinine
levels progressively increase and calcium
levels may fall.
48. Dyspnoea
• • Dyspnoea is a frequent problem and in
some patients respiratory failure may require
intermittent positive pressure ventilation
• The respiratory problems are due to fluid
retention, with fluid overload giving rise to
pulmonary as well as systemic oedema
• Metabolic acidosis and pulmonary infection
may contribute further to the respiratory
difficulties.
49. Hypertension
• • Hypertension may be a consequence of fluid
overload and retention of K+ may give rise to
arrhythmias.
50. Gastrointestinal symptoms
• Gastrointestinal symptoms range from
nausea and vomiting due to water intoxication
to hiccups and diarrhoea, which frequently
accompany uraemia.
• Stress ulceration and gastric erosions are
common with ARF following shock, and
gastrointestinal haemorrhage may be severe
51. Cerebral Edema
• • Cerebral oedema and toxic metabolites
cause :-
• Confusion
• Drowsiness
• Eventually coma
52. A progressive anaemia
• • A progressive anaemia may develop and
coagulation defects may occur.
• Disseminated intravascular coagulation is a
not uncommon development.
53. Generalized impairment of the
immune system
• Finally, there is a generalized impairment of
the immune system, increasing the risk of
serious infection, which is probably the
commonest cause of death in ARF.
• The indiscriminate use of antibiotics
exacerbates this risk by promoting the
development of resistant strains of pathogenic
bacteria.
57. Prevention
• Prevention ARF may be prevented by careful
attention to
• 1- Preoperative fluid balance
• 2- Proper monitoring of the patient
peroperatively
• 3- Avoidance of hypotension and sepsis.
58. Prevention
• Patients at risk of developing renal failure, e.g.
those with obstructive jaundice, should have
an intravenous infusion established the night
before surgery so that they are well hydrated.
59. Prevention
• Remember that patients are starved prior to
surgery and will not be allowed oral fluids for
about 12 h (but often longer) before surgery.
60. Prevention
• Patients undergoing major surgery should
have a urinary catheter for hourly
measurement of urine output during surgery
and in the postoperative period.
61. Prevention
• A central venous line and arterial line are
usually inserted by the anaesthetist for
haemodynamic monitoring
62. Drugs avoid renal failure
• Some drugs may help to avoid renal failure in
certain situations.
• Dopamine, which at low doses (< 5 ug/kg per
min) induces vasodilatation and increased renal
perfusion, is frequently given to at-risk patients in
an attempt to preserve renal function.
• Mannitol, an osmotic diuretic, may also protect
renal function in some patients, such as those
with obstructive jaundice or those at risk of
rhabdomyolysis (e.g. following arterial
embolectomy).
63. Patients receiving nephrotoxic drugs
• Patients receiving known nephrotoxic drugs
should have their renal function monitored
regularly.
64. Patients receiving nephrotoxic drugs
• In the case of aminoglycosides, plasma
concentrations should be measured 1 h after
intramuscular or intravenous administration
and just prior to the administration of the next
dose.
• This ensures that excessive and
subtherapeutic doses are avoided.
65. Patients receiving nephrotoxic drugs
• For gentamicin, the peak level should not
exceed 10 mg/L, while the trough level should
be less than 2 mg/L.
66. Conservative Treatment
• Identification and correction/removal of the
cause is essential and any sepsis treated with
a third-generation cephalosporin in the first
instance.
• In oliguric patients with adequate circulating
volume, intravenous diuretic is administered
and may promote a diuresis.
• Removal of obstruction is necessary in
obstructive anuria.
67. • Conservative management of intrinsic renal
failure is only possible when the patient's
condition is not so severe as to warrant
immediate renal replacement therapy (RRT).
68. Conservative management consists of:
• Restriction of fluid intake to cover daily estimated
losses (insensible perspiration and stools);
• Restriction of first-class protein to 30 g/day to
reduce nausea and anorexia;
• Restriction of potassium intake to 20 mmol/day
to minimize risk of hyperkalaemia
• Correction of biochemical abnormalities
• Maintenance of adequate nutrition, including
parenteral nutrition (if required)
69. Conservative management consists of:
• Hyperkalaemia is the most serious
biochemical abnormality since it can cause
cardiac arrhythmias and sudden death.
• Prompt detection and treatment are thus
essential
70. Treatment of hyperkalaemia
• Calcium gluconate or chloride of 10% 10-20
ml i.v.
• Dextrose 50% 50 ml of i.v. with 10 units of
soluble insulin
• Sodium bicarbonate of 1.4% 200-300 ml i.v.
• Calcium resonium 15 g three times daily orally
or by enema
• Dialysis
71. Treatment of hyperkalaemia
• 10-20 ml of 10% calcium gluconate or chloride
i.v.: has no effect on the serum potassium
concentration but stabilizes the myocardial
membrane
72. Treatment of hyperkalaemia
• 50 ml of 50% dextrose i.v. with 10 units of
soluble insulin:-
• drives potassium into the cells and should be
started directly after step 1
73. Treatment of hyperkalaemia
• 200-300 ml of 1.4% sodium bicarbonate i.v.:-
drives potassium into cells and helps to
correct the acidosis of acute renal failure.
• However, the fluid load necessary makes use
of this agent less desirable in hyperkalaemic
acute renal failure
74. Treatment of hyperkalaemia
• Calcium resonium 15 g three times daily orally
or by enema:-
• binds potassium in the gut and releases
calcium in exchange.
• Unlike the other actions listed this can control
the serum potassium for hours to days
75. Treatment of hyperkalaemia
• Dialysis: should be implemented if there is
severe hyperkalaemia and/or the patient
requires dialysis for other reasons, e.g. fluid
overload
77. RRT
• Abnormalities of potassium, calcium and
phosphate can be corrected by the various
forms of RRT using dialysate or replacement
solutions
78. The Indications For RRT
• • Uraemia (significant retention of
nitrogenous waste products with associated
clinical signs)
• • Metabolic acidosis
• • Hyperkalaemia
• • Significant fluid overload
79. Type of therapy
• Treatment for the majority of patients with
ARF requires adequate vascular access, most
commonly achieved using the internal jugular
vein with subclavian or femoral vein as lesser
alternatives
80. • The use of the subclavian route carries an
increased risk of pneumothorax and venous
stenosis.
• The femoral route is only suitable for short
periods because of the high infection rate.
81. • Temporary lines may have a single, double or
triple lumen.
• Double- and triplelumen lines are associated
with improved clearance of uraemic toxins,
and the triple-lumen line allows
administration of intravenous therapy without
interfering with RRT.
82. The choice is between the following
• Haemodialysis: efficient small-molecule and
volume removal.
• Haemofiltration: removes large molecules and
volume by convection.
• Haemodiafiltration: combination of
haemodialysis and haemofiltration
83. Haemofiltration
• Haemofiltration uses a highly permeable
synthetic membrane and negative pressure in
the dialysate compartment of the dialyser
without dialysate flowing such that up to 80 L
of fluid are removed from the patient in a 4-h
session.
84. Haemofiltration
• Solute removal is by 'convection', or passive
flow of solute with water.
• The desired proportion of the filtrate is
replaced by infusion usually from preprepared
sterile bags of replacement fluid.
85.
86. Haemofiltration
• Convection allows greater removal of solutes
in the 'middle molecular' range (110-500 Da)
but is less efficient at the smaller end of the
molecular spectrum, which contains most of
the lifethreatening compounds
87. Haemodialysis
• Haemodialysis is based on diffusion across a
semipermeable membrane porous to
molecules under 500 Da.
• It thus exhibits high efficiency with regard to
small molecule and volume removal and is
cost-effective but relies on well-trained
personnel
88.
89. Haemodiafiltration
• The combination of these two techniques is
called haemodiafiltration.
• With this modality, the benefits of diffusion
and convection are combined in a dialysis
circuit similar to that used for haemofiltration
but with dialysis fluid being pumped round
the dialysate circuit.
90. Venovenous haemofiltration
• Venovenous haemofiltration requires at least
a doublelumen venous line and relies on a
pumped system to create a gradient across
the filter and hence a fitrate from the patient.
91. Arteriovenous haemofiltration
• If the patient is normotensive, it is possible to
use an arterial and venous line to create the
pressure gradient across the filter line
(arteriovenous haemofiltration), thus
removing the need for a pump in the circuit.
92. • The choice between these types of support is
normally decided by the renal physician and
intensivist.
93. • All three modalities of RRT can be performed
on an intermittent or continuous basis.
95. Haemofiltration and
haemodiafiltration
• Patients with uncomplicated ARF whose
cardiovascular system is stable are usually
treated with intermittent techniques
• More unstable patients, in whom fluid
removal is more difficult, benefit from
continuous therapies.
96. Continuous Treatment
• Continuous treatment is especially useful for
patients with cerebral oedema or hypoxia.
Intermittent haemodialysis is the treatment of
choice when there is a need for rapid removal
of water-soluble substances such as
potassium, myoglobin and drugs.
99. Nutritional management
• All patients with dialysis-dependent ARF have
higher nutritional requirements than normal,
especially if the ARF arises as a complication
of other severe illness.
100. State of patients with ARF
• Relative insulin-resistant state
• Low triiodothyronine
• Decreased testosterone
• Increased energy expenditure above expected
resting levels.
101. • Hyperglycaemia (insulin resistance) is not
uncommon and glucose oxidation forms a
smaller component of total energy
consumption.
102. • Lipid and protein metabolism is also
disturbed, with increased plasma triglycerides
and increased protein catabolism.
103. • RRT adds a further strain.
• Whilst the glucose in haemofiltration fluids
provides a large number of calories, amino
acids are lost during RRT.
104. • The haemodynamic state of the patient may
restrict the ability to supply the patient's
nutritional requirements.
105. • Patients with ARF have the same daily
requirements as other acutely sick patients,
i.e. a caloric intake of 35 kcal/kg (147 kj/kg)
body weight and nitrogen 1.2 g/kg body
weight, with the ratio between glucose and
lipid in the non-protein part of the diet being
70/30.
107. Diuretic phase
• As ARF resolves there is often a diuretic phase.
• This occurs because although filtration is
restored, the concentrating ability of the
recovering tubules has not.
108. Diuretic phase
• During this phase there is a risk of
dehydration.
• The excessive fluid loss (as much as 20 L/day)
must be replaced intravenously until the
tubules are able to concentrate the urine.
• High urinary volumes such as these are
unlikely to persist for more than a few days.
•
109. Diuretic phase
• The diuretic phase of renal failure may last
several weeks to months but is usually shorter
if patients do not become anuric or severely
oliguric.
111. • The prognosis of ARF depends on the underlying aetiology.
• The overall mortality has not changed materially
• during the past three decades and averages 50%. However,
• the mortality rate associated with certain categories of
• ARF has improved, e.g. ARF associated with trauma and
• obstetric disorders. Comorbid disease influences the outcome:
• ARF in patients nursed in intensive care units has
• an overall mortality of 70%. For all patients if there is associated
• failure of one other system the overall patient survival
• is less than 30% and failure of two systems reduces
• survival further to less than 10%. Increasing age also
• impacts adversely on survival.